McCulloch Kevin
SEC CIK 2031695 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| XERS | Xeris Biopharma Holdings, Inc. | See Remarks | 1.64M | $109.5K | $1.09M | 17 | 2024-08-01 | 2026-09-01 |
Most active insiders at XERS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hecht Beth | See Remarks | — | $1.31M |
| 2 | McCulloch Kevin | See Remarks | — | $1.09M |
| 3 | JOHNSON JOHN | Dir | — | $1.07M |
| 4 | Pieper Steven | See Remarks | — | $468.2K |
| 5 | Shannon John Patrick Jr | See Remarks, Dir | — | $349.7K |
| 6 | BORMANN-KENNEDY BARBARA-JEAN ANNE | Dir | — | $203.9K |
| 7 | HALKUFF DAWN | Dir | — | $121.9K |
| 8 | PERSKY MARLA | Dir | — | $91.4K |
| 9 | Brady James Aloysius | Dir | — | $60.0K |
| 10 | Nguyen Anh Tu | See Remarks | — | — |
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-01 18:21 | 2026-09-01 | XERS | Xeris Biopharma Holdings, Inc. | McCulloch Kevin | See Remarks | S - Sale | $8.49 | -15.0K | 1.64M | -0.9% | -$127.3K |
| 2026-08-21 16:15 | 2026-08-01 | XERS | Xeris Biopharma Holdings, Inc. | McCulloch Kevin | See Remarks | F - Tax | $8.08 | -21.9K | 1.65M | -1% | -$177.1K | |
| T | 2026-08-04 17:30 | 2026-08-03 | XERS | Xeris Biopharma Holdings, Inc. | McCulloch Kevin | See Remarks | S - Sale | $8.02 | -15.0K | 1.68M | -0.9% | -$120.2K |
| T | 2026-07-02 16:40 | 2026-07-01 | XERS | Xeris Biopharma Holdings, Inc. | McCulloch Kevin | See Remarks | S - Sale | $8.03 | -90.0K | 1.69M | -5% | -$722.5K |
| DM | 2026-03-16 | 2026-03-12 | XERS | Xeris Biopharma Holdings, Inc. | McCulloch Kevin | See Remarks | M - OptEx | $4.09 | +48.9K | 1.78M | +3% | +$200.0K |
| DM | 2026-02-02 | 2026-01-31 | XERS | Xeris Biopharma Holdings, Inc. | McCulloch Kevin | See Remarks | F - Tax | $7.36 | -126.1K | 1.73M | -7% | -$927.8K |
| D | 2026-02-02 | 2026-01-30 | XERS | Xeris Biopharma Holdings, Inc. | McCulloch Kevin | See Remarks | A - Grant | $0.00 | +168.5K | 1.85M | +10% | $0 |
| 2026-01-09 | 2026-01-08 | XERS | Xeris Biopharma Holdings, Inc. | McCulloch Kevin | See Remarks | S - Sale | $8.00 | -15.0K | 1.69M | -0.9% | -$120.0K | |
| 2025-10-03 | 2025-10-02 | XERS | Xeris Biopharma Holdings, Inc. | McCulloch Kevin | See Remarks | F - Tax | $8.31 | -733 | 1.70M | -0.0% | -$6,091 | |
| I | 2025-09-15 | 2025-09-11 | XERS | Xeris Biopharma Holdings, Inc. | McCulloch Kevin | See Remarks | J - Other | $0.00 | -2,000 | 0 | -100% | $0 |
| 2025-08-04 | 2025-08-01 | XERS | Xeris Biopharma Holdings, Inc. | McCulloch Kevin | See Remarks | F - Tax | $5.38 | -14.7K | 1.70M | -0.9% | -$78.8K | |
| 2025-06-16 | 2025-06-13 | XERS | Xeris Biopharma Holdings, Inc. | McCulloch Kevin | See Remarks | P - Purchase | $4.38 | +25.0K | 1.71M | +1% | +$109.5K | |
| 2025-04-03 | 2025-04-02 | XERS | Xeris Biopharma Holdings, Inc. | McCulloch Kevin | See Remarks | F - Tax | $5.15 | -733 | 1.68M | -0.0% | -$3,775 | |
| DM | 2025-02-03 | 2025-01-31 | XERS | Xeris Biopharma Holdings, Inc. | McCulloch Kevin | See Remarks | F - Tax | $3.56 | -78.1K | 1.55M | -5% | -$278.2K |
| D | 2025-02-03 | 2025-01-31 | XERS | Xeris Biopharma Holdings, Inc. | McCulloch Kevin | See Remarks | A - Grant | $0.00 | +185.0K | 1.68M | +12% | $0 |
| 2025-01-07 | 2025-01-03 | XERS | Xeris Biopharma Holdings, Inc. | McCulloch Kevin | See Remarks | F - Tax | $3.61 | -24.5K | 1.58M | -2% | -$88.4K | |
| D | 2024-08-02 | 2024-08-01 | XERS | Xeris Biopharma Holdings, Inc. | McCulloch Kevin | See Remarks | A - Grant | $0.00 | +150.0K | 1.60M | +10% | $0 |
Purchase Sale Sale after option exercise All abbreviations